A carregar...
Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy
Tumour infiltration by regulatory T (Treg) cells contributes to suppression of the anti‐tumour immune response, which limits the efficacy of immune‐mediated cancer therapies. The phosphoinositide 3‐kinase (PI3K) pathway has key roles in mediating the function of many immune cell subsets, including T...
Na minha lista:
| Publicado no: | Immunology |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587315/ https://ncbi.nlm.nih.gov/pubmed/31107985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imm.13082 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|